DK0689458T3 - Plaster med aktiv bestanddel til afgivelse af estradiol på huden - Google Patents

Plaster med aktiv bestanddel til afgivelse af estradiol på huden

Info

Publication number
DK0689458T3
DK0689458T3 DK94909117T DK94909117T DK0689458T3 DK 0689458 T3 DK0689458 T3 DK 0689458T3 DK 94909117 T DK94909117 T DK 94909117T DK 94909117 T DK94909117 T DK 94909117T DK 0689458 T3 DK0689458 T3 DK 0689458T3
Authority
DK
Denmark
Prior art keywords
pct
active substance
estradiol
skin
ch2oh
Prior art date
Application number
DK94909117T
Other languages
Danish (da)
English (en)
Inventor
Teresa Maria Murphy
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0689458T3 publication Critical patent/DK0689458T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK94909117T 1993-03-26 1994-03-07 Plaster med aktiv bestanddel til afgivelse af estradiol på huden DK0689458T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4309830A DE4309830C1 (de) 1993-03-26 1993-03-26 Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
PCT/EP1994/000670 WO1994022481A1 (fr) 1993-03-26 1994-03-07 Emplatre de matiere active pour administration d'oestradiol par la peau

Publications (1)

Publication Number Publication Date
DK0689458T3 true DK0689458T3 (da) 1999-08-09

Family

ID=6483909

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909117T DK0689458T3 (da) 1993-03-26 1994-03-07 Plaster med aktiv bestanddel til afgivelse af estradiol på huden

Country Status (23)

Country Link
US (1) US5686098A (fr)
EP (1) EP0689458B1 (fr)
JP (1) JPH08508266A (fr)
KR (1) KR960700754A (fr)
AT (1) ATE173636T1 (fr)
AU (1) AU681383B2 (fr)
CA (1) CA2156746A1 (fr)
CZ (1) CZ287544B6 (fr)
DE (2) DE4309830C1 (fr)
DK (1) DK0689458T3 (fr)
ES (1) ES2127384T3 (fr)
FI (1) FI954497A (fr)
GR (1) GR3029387T3 (fr)
HR (1) HRP940213A2 (fr)
HU (1) HU220861B1 (fr)
IL (1) IL109084A (fr)
NO (1) NO953792L (fr)
NZ (1) NZ262418A (fr)
PL (1) PL173547B1 (fr)
SK (1) SK280246B6 (fr)
WO (1) WO1994022481A1 (fr)
YU (1) YU14394A (fr)
ZA (1) ZA941987B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19702314C2 (de) * 1997-01-23 2000-12-21 Lohmann Therapie Syst Lts Ablösbare Schutzfolie für wirkstoffhaltige, insbesondere selbstklebende Pflastersysteme
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2869232B1 (fr) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US20060134188A1 (en) * 2004-12-20 2006-06-22 Hans-Peter Podhaisky Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
FR2912149B1 (fr) * 2007-02-05 2012-10-12 Rhodia Poliamida E Especialidades Ltda Utilisation de derives de dioxolane dans des systemes de revetement et formulation de systeme de revetement
CA2696632C (fr) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. Formulations anesthesiques locales a concentration elevee
DE102008059054A1 (de) * 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
JP5639208B2 (ja) * 2013-02-22 2014-12-10 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダRhodia Poliamida E Especialidades Ltda コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
JP5576523B2 (ja) * 2013-02-22 2014-08-20 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
CN116157211B (zh) * 2020-08-26 2024-03-08 中国涂料株式会社 低voc涂料组合物、涂膜和具有涂膜的基材以及它们的制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1385914A (en) * 1971-10-19 1975-03-05 Wigglesworth Ltd Compositions having bactericidal activity
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
WO1991005529A1 (fr) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Systemes d'apport de medicaments et matrice prevue a cet effet
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system

Also Published As

Publication number Publication date
JPH08508266A (ja) 1996-09-03
HRP940213A2 (en) 1998-02-28
EP0689458A1 (fr) 1996-01-03
SK280246B6 (sk) 1999-10-08
HUT73425A (en) 1996-07-29
NO953792D0 (no) 1995-09-25
ATE173636T1 (de) 1998-12-15
WO1994022481A1 (fr) 1994-10-13
GR3029387T3 (en) 1999-05-28
FI954497A0 (fi) 1995-09-22
ZA941987B (en) 1995-04-05
CA2156746A1 (fr) 1994-10-13
PL310555A1 (en) 1995-12-27
IL109084A (en) 1996-12-05
CZ248995A3 (en) 1996-03-13
IL109084A0 (en) 1994-06-24
YU14394A (sh) 1997-01-08
HU9502794D0 (en) 1995-11-28
AU6208394A (en) 1994-10-24
PL173547B1 (pl) 1998-03-31
DE59407345D1 (de) 1999-01-07
AU681383B2 (en) 1997-08-28
HU220861B1 (en) 2002-06-29
SK120695A3 (en) 1997-02-05
ES2127384T3 (es) 1999-04-16
EP0689458B1 (fr) 1998-11-25
NO953792L (no) 1995-09-25
US5686098A (en) 1997-11-11
CZ287544B6 (en) 2000-12-13
FI954497A (fi) 1995-09-22
KR960700754A (ko) 1996-02-24
NZ262418A (en) 1996-08-27
DE4309830C1 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
DK0689458T3 (da) Plaster med aktiv bestanddel til afgivelse af estradiol på huden
DE59405920D1 (de) Wirkstoffhaltiges pflaster
FI953533A (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
DK0802789T3 (da) Estradiolholdigt plaster
CZ102295A3 (en) Plaster for transdermal application of volatile, pharmaceutically active chemically basic active compounds and process for preparing thereof
YU2594A (sh) Flaster koji sadrži nitroglicerin i postupak za njegovo dobijanje
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.